Clinical trials
Completed Glaucoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
796 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 5 |
| 2002 | 7 |
| 2003 | 16 |
| 2004 | 13 |
| 2005 | 29 |
| 2006 | 34 |
| 2007 | 44 |
| 2008 | 36 |
| 2009 | 50 |
| 2010 | 49 |
| 2011 | 49 |
| 2012 | 37 |
| 2013 | 43 |
| 2014 | 51 |
| 2015 | 33 |
| 2016 | 32 |
| 2017 | 36 |
| 2018 | 36 |
| 2019 | 32 |
| 2020 | 23 |
| 2021 | 30 |
| 2022 | 20 |
| 2023 | 20 |
| 2024 | 19 |
| 2025 | 14 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 796 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 69 |
| Wills Eye | 34 |
| Allergan | 31 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 14 |
| Aerie Pharmaceuticals | 13 |
| Glaukos Corporation | 13 |
| Aristotle University Of Thessaloniki | 11 |
| Medical University of Vienna | 9 |
| Sensimed AG | 9 |
| University of Zurich | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 796 |
| Ocular Hypertension | 237 |
| Glaucoma, Open-Angle | 183 |
| Cataract | 40 |
| Eye Diseases | 27 |
| Macular Degeneration | 20 |
| Hypertension | 19 |
| Diabetic Retinopathy | 16 |
| Low Tension Glaucoma | 16 |
| Exfoliation Syndrome | 12 |
Trials
Showing 76 to 100 of 796. Each trial links to its page on Pharma Observatory.
696 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.